✦ LIBER ✦

NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome

✍ Scribed by Villamor, N; Conde, L; Martínez-Trillos, A; Cazorla, M; Navarro, A; Beà, S; López, C; Colomer, D; Pinyol, M; Aymerich, M; Rozman, M; Abrisqueta, P; Baumann, T; Delgado, J; Giné, E; González-Díaz, M; Hernández, J M; Colado, E; Payer, A R; Rayon, C; Navarro, B; José Terol, M; Bosch, F; Quesada, V; Puente, X S; López-Otín, C; Jares, P; Pereira, A; Campo, E; López-Guillermo, A

Book ID: 120345689
Publisher: Nature Publishing Group
Year: 2012
Tongue: English
Weight: 939 KB
Volume: 27
Category: Article
ISSN: 0887-6924
DOI: 10.1038/leu.2012.357

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

NOTCH1mutations identify a chronic lymph

NOTCH1mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment

✍ Bo, Michele Dal; Del Principe, Maria Ilaria; Pozzo, Federico; Ragusa, Dario; Bul 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 1004 KB

Elevated serum levels of soluble CD44 ca

Elevated serum levels of soluble CD44 can identify a subgroup of patients with early B-cell chronic lymphocytic leukemia who are at high risk of disease progression

✍ Stefano Molica; Gaetano Vitelli; Domenico Levato; Diana Giannarelli; Giuseppe Ma 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 2 views

TP53 codon 72 polymorphism in patients w

TP53 codon 72 polymorphism in patients with chronic lymphocytic leukaemia: identification of a subgroup with mutated IGHV genes and poor clinical outcome

✍ Aneela Majid; Tom Richards; Palminder Dusanjh; D. Benjamin J. Kennedy; Fiona Mia 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB

Chronic eosinophilic leukemia-not otherw

Chronic eosinophilic leukemia-not otherwise specified has a poor prognosis with unresponsiveness to conventional treatment and high risk of acute transformation

✍ Grzegorz Helbig; Anna Soja; Aleksandra Bartkowska-Chrobok; Sławomira Kyrcz-Krzem 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 756 KB

PCN67 COST UTILITY ANALYSIS OF ALEMTUZUM

PCN67 COST UTILITY ANALYSIS OF ALEMTUZUMAB COMPARED TO CHLORAMBUCIL IN UNTREATED PATIENTS WITH HIGH-RISK (17P-) CHRONIC LYMPHOCYTIC LEUKEMIA IN THE UNITED KINGDOM

✍ AC Lloyd; A Valderrama; J Ferguson; L Gilmour; F Ravndal 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

Early Results of a Phase II Study Adding

Early Results of a Phase II Study Adding Peri-Transplant Rituximab to Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation (HCT) for Patients (PTS) with High-Risk Fludarabine-Refractory Chronic Lymphocytic Leukemia (Cll)

✍ M.L. Sorror; B. Storer; B.M. Sandmaier; T. Chauncey; B. Bruno; N.N.S. Andersen; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 93 KB